| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |